© 2004 by Oxford University Press
© 2004 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles
Affiliations of authors: Laboratory of Cellular Oncology, Center for Cancer Research (DRL, JTS), Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics (AH), National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Gynecology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (DNH).
Correspondence to: Douglas R. Lowy, MD, Laboratory of Cellular Oncology, Bldg. 37, Rm. 4106, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 (e-mail: drl@helix.nih.gov)
| The first 10% of the full text of this article appears below. |
We thank Drs. Barr and Koutsky for their comments related to our recently published article, in which we reported that human papillomavirus 16 (HPV16) antibody levels at the cervix, following systemic immunization with